Crossmark

MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer

Published Online: 2021-11-18

Published Print: 2021-12

Authors

Lee, Sung Hwan https://orcid.org/0000-0003-3365-0096
Hwang, Ho Kyoung

Lee, Woo Jung

Kang, Chang Moo
Funding

Funding for this research was provided by:

Yonsei University College of Medicine (6-2015-0053)
License Information

Text and Data Mining valid from 2021-11-18

Version of Record valid from 2021-11-18
More Information

Article History

Accepted: 22 October 2021

First Online: 18 November 2021

Declarations

:

: The authors declare that they have no competing interests.

Document is current